hyaline membrane disease

1. OBJECTIVE To investigate the way to increase the survival from the hyaline membrane disease.
   目的探讨提高新生儿肺透明膜病生存率的方法。
2. Observation effect on curosurf in prevention hyaline membrane disease of premature
   固尔苏预防早产儿肺透明膜病的效果观察
3. Preterm hyaline membrane disease;
   肺透明膜病；
4. CONCLUSIONS Good curing, nursing care and quality control for nosocomial infection will increase the survival from the hyaline membrane disease.
   结论合适的治疗方法、有效的护理措施和医院感染控制可提高患儿的生存率。
5. Objective: To explore the effect of mechanical ventilation ( MV) on premature infants with hyaline membrane disease ( HMD) and its problems.
   目的探讨分析应用机械通气治疗早产儿肺透明膜病（HMD）近期效果及存在的问题。
6. The Preventive Effect of Different Delivery Ways of Ambroxol Hydrochloride on Hyaline Membrane Disease in Newborns Study of different modes of catheter-directed thrombolysis with recombinant staphylokinase in lower extremity deep venous thrombosis
   盐酸氨溴索不同给药方式对预防新生儿早产肺透明膜病观察导管介入溶栓治疗下肢深静脉血栓形成不同给药方式的疗效分析
7. Nursing of neonate hyaline membrane disease treated with high frequency oscillatory ventilation
   高频振荡通气治疗新生儿重症肺透明膜病的护理
8. Objective To investigate the imaging features of pulmonary hyaline membrane disease ( PHMD) in newborns.
   目的探讨新生儿肺透明膜病的影像特征。
9. Objective: To study the high risk factors related with the morbidity in hyaline membrane disease ( HMD) of premature infants, in order to obtain the effective measure for prevention and treatment.
   目的：分析与早产儿肺透明膜病（hyalinemembranedisease，HMD）发病相关的高危因素，以探讨有效的防治措施。
10. Objective: To explore the increase of success rate of rescue and the improvement of nursing quality for the premature with hyaline membrane disease.
    目的：提高早产儿肺透明膜病的抢救成功率和护理质量。
11. Objective To study the expression of surfactant protein B ( SP-B) and thyroid transcription factor-1 ( TTF-1) and detect the mutation of SP-B gene in the newborns with hyaline membrane disease ( HMD) in order to evaluate the role of SP-B and its molecular mechanism.
    目的研究表面活性蛋白B（SP-B）、甲状腺转录因子1（TTF-1）在新生儿肺透明膜病中的表达与分布，并分析SP-B基因结构变化，探讨SP-B在肺透明膜病中的作用。
12. The association between hyaline membrane disease and preeclampsia
    新生儿肺透明膜病和先兆子痫的关系
13. Objective To investigate and evaluate the application and safety of high frequency oscillatory ventilation in the treatment of neonates with hyaline membrane disease ( HMD).
    目的探讨高频振荡通气在治疗新生儿肺透明膜病（HMD）中的应用价值及其安全性。
14. Result The first 6 death causes were amniotic fluid aspiration pneumonia, malformation, hyaline membrane disease, intracranial hemorrhage, infectious pneumonia and amniotic fluid aspiration.
    结果前6位死因是羊水吸入性肺炎、畸形、肺透明膜病、颅内出血、感染性肺炎及羊水吸入；
15. Neonatal pulmonary hyaline membrane disease is a serious disease in the early newborn.
    新生儿肺透明膜病是新生儿早期的严重疾病。
16. Objectives To study the expression of surfactant protein B ( SP-B) and thyroid transcription factor 1 ( TTF-1) and evaluate the role in neonatal hyaline membrane disease ( NHMD).
    目的探讨表面活性蛋白B（SP-B）与甲状腺转录因子（TTF-1）在新生儿肺透明膜病中的表达及其意义。
17. The Clinical and Pathological Study of Perinatal Pulmonary Hyaline Membrane Disease in 44 Cases
    44例围产儿肺透明膜病的临床和病理研究
18. Significance of respiratory mechanics dynamic monitoring in hyaline membrane disease with ventilation
    呼吸力学监测在肺透明膜病机械通气中的意义
19. Premature delivery is the main cause of neonatal morbidity and mortality. Asphyxia. hyaline membrane disease of the newborn ( HMD) and intracranial hemorrhage are common complications and main causes of neonate death.
    结论：早产因素多且复杂，早产是新生儿发病和死亡的主要原因，新生儿窒息、肺透明膜病及颅内出血是早产儿常见并发症，且是导致新生儿死亡的主要原因。
20. The influence of hypoxia-ischemia in prenatal period on the onset and prognosis of hyaline membrane disease in premature infants
    胎儿期缺氧缺血对早产儿肺透明膜病发病和预后影响
21. Conclusions Prenatal therapy of corticoid for preterm infants less than 34 gestational weeks can reduce the incidence of hyaline membrane disease.
    结论产前糖皮质激素治疗对小于孕34周早产儿有降低肺透明膜病的发生的积极预防作用。
22. In this paper, we observed the pathological manifestation of all kinds of disease and made an inquiry into the reason and prevention of hereditary malformation and hyaline membrane disease of newborn.
    本文对各种疾病的病理表现进行了观察，并对新生儿肺透明膜病及先天畸形的原因及其预防进行了讨论。
23. Role of Surfactant Protein B in Newborns with Hyaline Membrane Disease
    表面活性蛋白B在新生儿肺透明膜病中的作用
24. Clinical Study on Curing Hyaline Membrane Disease with Pulmonary Surfactant
    肺表面活性物质替代治疗新生儿肺透明膜病临床研究
25. Expression of surfactant protein B and thyroid transcription factor 1 in the neonates with hyaline membrane disease
    表面活性蛋白B、甲状腺转录因子在新生儿肺透明膜病中的表达及意义
26. The relation of neonatal hyaline membrane disease and congenital human cytomegalovirus infection
    新生儿肺透明膜病与先天性人巨细胞病毒感染的相关性
27. Ambroxol and Corticosteroid Usage in the Prevention of Neonatal Pulmonary Hyaline Membrane Disease
    盐酸氨溴索与激素联合使用预防新生儿肺透明膜病
28. Clinical analysis of the complications in hyaline membrane disease
    新生儿肺透明膜病急性期并发症临床分析
29. In the premature infant hyaline membrane disease, SP-B is absent because of the immaturity of alveolar type ⅱ epithelial cells.
    在早产儿肺透明膜病中，SP-B缺乏的主要机制为肺泡Ⅱ型上皮细胞发育不成熟。

noun

1. an acute lung disease of the newborn (especially the premature newborn)

   Synonym:    respiratory distress syndromerespiratory distress syndrome of the newborn